Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) EBT Margin (2021 - 2026)

Bioceres Crop Solutions' EBT Margin history spans 4 years, with the latest figure at 36.91% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 3452.0% to 36.91% in Q1 2026 year-over-year; TTM through Mar 2026 was 27.4%, a N/A change, with the full-year FY2025 number at 17.27%, down 1965.0% from a year prior.
  • EBT Margin hit 36.91% in Q1 2026 for Bioceres Crop Solutions, down from 2.4% in the prior quarter.
  • Over the last five years, EBT Margin for BIOX hit a ceiling of 2.4% in Q1 2025 and a floor of 83.18% in Q2 2022.
  • Historically, EBT Margin has averaged 40.83% across 3 years, with a median of 36.91% in 2026.
  • Biggest five-year swings in EBT Margin: skyrocketed 240207bps in 2022 and later tumbled -3452bps in 2026.
  • Tracing BIOX's EBT Margin over 3 years: stood at 83.18% in 2022, then surged by 97bps to 2.4% in 2025, then tumbled by -1441bps to 36.91% in 2026.
  • Business Quant data shows EBT Margin for BIOX at 36.91% in Q1 2026, 2.4% in Q1 2025, and 83.18% in Q2 2022.